|
1
|
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
|
J Endocrinol
|
2007
|
2.31
|
|
2
|
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
|
N Engl J Med
|
2008
|
2.01
|
|
3
|
Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
|
Kidney Int
|
2010
|
1.70
|
|
4
|
Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
|
World J Surg
|
2002
|
1.35
|
|
5
|
25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands.
|
J Clin Endocrinol Metab
|
2002
|
1.24
|
|
6
|
Surgical treatment of Graves' disease: evidence-based approach.
|
World J Surg
|
2008
|
1.15
|
|
7
|
The internally truncated LRP5 receptor presents a therapeutic target in breast cancer.
|
PLoS One
|
2009
|
1.12
|
|
8
|
Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors.
|
World J Surg
|
2008
|
1.05
|
|
9
|
An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling.
|
PLoS Med
|
2007
|
1.03
|
|
10
|
Molecular genetics of parathyroid disease.
|
World J Surg
|
2009
|
1.01
|
|
11
|
25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
|
Breast Cancer Res
|
2005
|
1.01
|
|
12
|
Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
|
Clin Endocrinol (Oxf)
|
2004
|
0.98
|
|
13
|
High success rate of parathyroid reoperation may be achieved with improved localization diagnosis.
|
World J Surg
|
2008
|
0.97
|
|
14
|
Cyclin-dependent kinase 4 (CDK4) expression in pancreatic endocrine tumors.
|
Neuroendocrinology
|
2007
|
0.96
|
|
15
|
Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors.
|
J Clin Endocrinol Metab
|
2006
|
0.94
|
|
16
|
Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors.
|
World J Surg
|
2002
|
0.94
|
|
17
|
Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability.
|
PLoS One
|
2010
|
0.93
|
|
18
|
Stenting of the superior mesenteric vein in midgut carcinoid disease with large mesenteric masses.
|
World J Surg
|
2010
|
0.91
|
|
19
|
The DNA methylome of benign and malignant parathyroid tumors.
|
Genes Chromosomes Cancer
|
2011
|
0.90
|
|
20
|
Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients.
|
Mol Cancer
|
2008
|
0.90
|
|
21
|
Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism.
|
Clin Endocrinol (Oxf)
|
2002
|
0.89
|
|
22
|
Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis.
|
Endocr Relat Cancer
|
2010
|
0.89
|
|
23
|
Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
|
J Clin Endocrinol Metab
|
2008
|
0.88
|
|
24
|
Aberrant WNT/β-catenin signaling in parathyroid carcinoma.
|
Mol Cancer
|
2010
|
0.88
|
|
25
|
Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
|
Endocrine
|
2012
|
0.83
|
|
26
|
Allelic loss in clinically and screening-detected primary hyperparathyroidism.
|
Clin Endocrinol (Oxf)
|
2002
|
0.82
|
|
27
|
Mutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic malignant pancreatic endocrine tumours.
|
Clin Endocrinol (Oxf)
|
2007
|
0.82
|
|
28
|
Bilateral adrenalectomy for ectopic Cushing's syndrome-discussions on technique and indication.
|
World J Surg
|
2006
|
0.81
|
|
29
|
Prophylactic cholecystectomy in midgut carcinoid patients.
|
World J Surg
|
2010
|
0.81
|
|
30
|
Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
|
Neoplasia
|
2007
|
0.80
|
|
31
|
Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
|
Clin Endocrinol (Oxf)
|
2007
|
0.80
|
|
32
|
Vitamin D3 polyunsaturated side-chain analogues (EB1089, GS1590) and the 20-epi-vitamin D3 analogue CB1393 suppress parathyroid hormone secretion and mRNA level in bovine parathyroid cells.
|
J Steroid Biochem Mol Biol
|
2004
|
0.78
|
|
33
|
Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH.
|
Int J Cancer
|
2006
|
0.78
|
|
34
|
Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
|
Int J Mol Med
|
2005
|
0.77
|
|
35
|
Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
|
Clin Endocrinol (Oxf)
|
2007
|
0.76
|
|
36
|
PET-Guided Surgery - High Correlation between Positron Emission Tomography with 11C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours.
|
Cancers (Basel)
|
2012
|
0.75
|